Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ...
Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children. The result of the existing programs has been a decrease in serogroup C incide...
Main Authors: | , , , , , , |
---|---|
Format: | Text |
Language: | English |
Published: |
The University of British Columbia
2016
|
Subjects: | |
Online Access: | https://dx.doi.org/10.14288/1.0228249 https://doi.library.ubc.ca/10.14288/1.0228249 |
id |
ftdatacite:10.14288/1.0228249 |
---|---|
record_format |
openpolar |
spelling |
ftdatacite:10.14288/1.0228249 2024-04-28T08:32:57+00:00 Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... Le Saux, Nicole Bettinger, Julie A. Wootton, Susan Halperin, Scott A. Vaudry, Wendy Scheifele, David W. Tsang, Raymond 2016 https://dx.doi.org/10.14288/1.0228249 https://doi.library.ubc.ca/10.14288/1.0228249 en eng The University of British Columbia article-journal Text ScholarlyArticle 2016 ftdatacite https://doi.org/10.14288/1.0228249 2024-04-02T09:52:39Z Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children. The result of the existing programs has been a decrease in serogroup C incidence. The second most common vaccinepreventable serogroup in Canada is serogroup Y, the incidence of which has been stable. The availability of a quadrivalent conjugate vaccine against serogroups A, C, Y and W135 focuses attention on serogroup Y disease as it becomes relatively more prominent as a cause of vaccine-preventable invasive meningococcal disease. This vaccine was licensed in November 2006 but is not routinely used except in Nunavut, New Brunswick and Prince Edward Island. To allow a better understanding of the ‘value added’ by a serogroup Y-containing vaccine, it is necessary to have a contemporary profile of Y disease in Canada. In the present paper, recent surveillance data on invasive meningococcal ... Text Nunavut Prince Edward Island DataCite Metadata Store (German National Library of Science and Technology) |
institution |
Open Polar |
collection |
DataCite Metadata Store (German National Library of Science and Technology) |
op_collection_id |
ftdatacite |
language |
English |
description |
Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children. The result of the existing programs has been a decrease in serogroup C incidence. The second most common vaccinepreventable serogroup in Canada is serogroup Y, the incidence of which has been stable. The availability of a quadrivalent conjugate vaccine against serogroups A, C, Y and W135 focuses attention on serogroup Y disease as it becomes relatively more prominent as a cause of vaccine-preventable invasive meningococcal disease. This vaccine was licensed in November 2006 but is not routinely used except in Nunavut, New Brunswick and Prince Edward Island. To allow a better understanding of the ‘value added’ by a serogroup Y-containing vaccine, it is necessary to have a contemporary profile of Y disease in Canada. In the present paper, recent surveillance data on invasive meningococcal ... |
format |
Text |
author |
Le Saux, Nicole Bettinger, Julie A. Wootton, Susan Halperin, Scott A. Vaudry, Wendy Scheifele, David W. Tsang, Raymond |
spellingShingle |
Le Saux, Nicole Bettinger, Julie A. Wootton, Susan Halperin, Scott A. Vaudry, Wendy Scheifele, David W. Tsang, Raymond Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... |
author_facet |
Le Saux, Nicole Bettinger, Julie A. Wootton, Susan Halperin, Scott A. Vaudry, Wendy Scheifele, David W. Tsang, Raymond |
author_sort |
Le Saux, Nicole |
title |
Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... |
title_short |
Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... |
title_full |
Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... |
title_fullStr |
Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... |
title_full_unstemmed |
Profile of serogroup Y meningococcal infections in Canada : implications for vaccine selection ... |
title_sort |
profile of serogroup y meningococcal infections in canada : implications for vaccine selection ... |
publisher |
The University of British Columbia |
publishDate |
2016 |
url |
https://dx.doi.org/10.14288/1.0228249 https://doi.library.ubc.ca/10.14288/1.0228249 |
genre |
Nunavut Prince Edward Island |
genre_facet |
Nunavut Prince Edward Island |
op_doi |
https://doi.org/10.14288/1.0228249 |
_version_ |
1797589952979009536 |